```
## Active Trials | NCT ID | Title | Status | Phase | Sponsor
| NCT05166889 | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations | Recruiting | Phase 3 | Unknown |
| NCT05384938 | FAsenra Safety Trial in India | Active, not recruiting | Phase 4 | Unknown |

Source: ClinicalTrials.gov

Total found: 2
```

These trials signify ongoing research within the area of respiratory diseases in India, suggesting that while the competition might be perceived as low at a glance, there are significant trials in progress, which may imply a high patent burden stemming from the therapeutic options under investigation. Further analysis of current patents related to these drugs could provide more clarity on the competitive landscape.